Mark Milton-Edwards, Teva Pharmaceuticals - Qepler Summits And Conferences

Mark Milton-Edwards

Head of Product & Health Solutions, Digital Health
Teva Pharmaceuticals
Tytherington, United Kingdom
At Teva Pharmaceutical Industries,  we improve people's health through our products, integrated R&D, generic medicines and global businesses

Mark is responsible for the Product & Health Solutions within Digital Health at TEVA Pharmaceuticals.

Over ten years with TEVA and prior to that sixteen with AstraZeneca. Mark has held various positions including R&D Project Leader, VP Sales & Marketing, Strategic Planning & Business Development, and Global Brand Lead.

Graduated in Aeronautical Sciences and completed his MBA at Durham University, UK.

During his career he has led technology & especially inhaler development teams through engineering, CMC characterisation, clinical evidence generation, registration within US, EU and International Markets and ultimately to successful global launch. Total Brand Leadership value >$2.5bn.

Mark has numerous patents granted and pending in electronic communications, sports technologies, inhaled pharmaceutical development, and respiratory physiological function & predictive AI. Mark is the inventor of Digihaler®, the first FDA approved digital inhaler with built-in sensors.

Related Sessions:

2nd Annual Inhaled
Drug Delivery Summit 2020

Assess and harness novel approaches to the development of inhaled drug products for enhanced patient care.
  • 17 Sep 2020
  • Prague, CZ
  • Pharma
Day 2: Friday, 18 September 2020
CASE STUDY: To Be Announced.
View Details